Recent reports suggest that the Idylla assay is not suitable for the assessment of cytological FFPE samples in the setting of EGFR TKI-resistance [13, 14] This study aimed to evaluate the IdyllaTM platform for cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.